Introduction
Marfan’s syndrome (MFS) is an autosomal dominant condition with many symptoms. It particularly involves the skeletal system, eyes, heart, blood vessels, and other organs. It affects both males and women equally. However, pregnant women with MFS are at an increased risk of complications. Hence, a systematic approach is required to manage it effectively with minimal maternal and fetal difficulties.
What Are the Causes of Marfan’s Syndrome?
Marfan’s syndrome is caused due to a gene mutation (FBN1). The affected gene helps control the formation of fibrillin, a protein that makes the connective tissue elastic and strong. Hence, the mutation results in an abnormal connective tissue structure. If the aorta (the main artery carrying blood to the whole body) gets affected, it can become fatal.
What Is the Risk for a Pregnant Woman With Marfan’s Syndrome?
Pregnancy is an emotional course for a woman. Moreover, the body is already undergoing various dynamic physical changes. Some examples are increased blood volume, blood pressure, heart rate, and hormonal variations. As a result, pregnant women with Marfan's syndrome are at an increased risk of aortic dissection (AoD), a tear in the inner layer of the major artery supplying the whole body. There are two types of AoDs:
-
Type A AoD: The tear is in the upper part of the aorta, where it exits the heart. This type is more dangerous and common.
-
Type B AoD: A tear in the aorta's lower part.
Pregnant women with aortic root diameters of more than four centimeters (cm) are at a greater risk of developing AoD than those with less than four cm. AoD mostly occurs in the third trimester of pregnancy or after delivery. It is an emergency state requiring immediate treatment. Type A AoD is an extremely dangerous condition. Other risks include arrhythmias, lung edema, and myocardial infarction.
What Are the Fetal Risks and Associated Complications?
The chances of transmitting MFS to the child are about 50 %. Due to a different clinical presentation in each pregnancy, the outcome can be mild, moderate, or severe. The mother with AoD increases the risk to the fetus. Complications such as premature birth, growth retardation in the womb, blood clotting, or even newborn death are present. After childbirth, blood tests are important to determine the genetic cause. Parents should do periodic follow-ups after birth to monitor signs of MFS.
How Is Marfan’s Syndrome Diagnosed in a Pregnant Woman?
Before planning a pregnancy, the couple should consult a gynecologist. A complete medical and family history is pertinent. Genetic testing is used for MFS diagnosis during pregnancy. Techniques, namely, chorionic villus sampling and amniocentesis, are frequently employed.
How Is Aortic Dissection Diagnosed in a Pregnant Patient With Marfan’s Syndrome?
MFS is unsuspected in some cases if AoD is present. Aortic size measurement can be assessed before conception using ultrasound, magnetic resonance imaging (MRI), computed tomography (CT), Transthoracic echocardiography (TTE), and Transesophageal echocardiography (TEE). The concerned doctors must be aware of AoD. It presents with severe chest, back, and abdominal pain, vomiting, and sudden loss of consciousness. Therefore, it becomes crucial for the emergency physician to diagnose and manage it promptly for an event-free pregnancy. Various diagnostic tests are available:
-
Ultrasound: Ultrasound is the most effective and readily available diagnostic method for AoD detection during the third trimester. In an emergency, it helps in a quick intervention.
-
TTE: It should be the first imaging technique to view the aorta in patients with chest pain. It allows a clearer picture of the chest cavity. Sometimes, TTE is combined with CT for better visualization.
-
TEE: This method is the gold standard in diagnosing AoD. It uses ultrasound technology to assess AoD. However, in a critical situation, it is not feasible.
-
Chest X-Ray: It shows abnormalities in about 85 % of the cases.
-
Electrocardiogram (ECG): Abnormal ECG is found.
What Is the Treatment for Marfan’s Syndrome in a Pregnant Patient?
Conservative treatments aim at alleviating the symptoms. These include pain medications, physical therapy, and many lifestyle modifications. In a pregnant woman, the following treatments are paramount:
-
Medications: Beta-blockers, namely Propranolol, Metoprolol, and Atenolol, are used. Atenolol is the drug of choice as it is safer and has few side effects. Doses up to 10 mg (milligram) four times daily are effective. Angiotensin-converting enzyme (ACE) inhibitors (Captopril, Enalapril) and angiotensin receptor blockers (ARBs), such as Losartan, are contraindicated in pregnancy due to the possibility of fetal toxicity.
-
Surgical Therapy:
-
Before Pregnancy: Surgery is controversial according to various countries’ cardiology societies. In addition, strict guidelines regarding prophylactic aortic root replacement suggest no safe aortic root diameter in pregnancy. Hence, women with MFS with an aortic root diameter of more than 4.5 cm should contemplate pregnancy.
-
During Pregnancy: Heart surgery for AoD poses an increased threat to the mother and fetus. Surgery in high-risk cases has presented mixed results. Emergency surgery, if needed, should be done in a hospital with a neonatal intensive care unit (NICU). Elective surgery for aortic repair should be performed a few days post-delivery. Recently, surgery has been initiated for type B AoD patients in MFS with good results.
What Are the Pregnancy Considerations in Women With Marfan’s Syndrome?
MFS is managed in a pregnant woman according to the stages of pregnancy. Therefore, doctors should start management ideally before conception.
-
Before Pregnancy: An interprofessional team comprising cardiologists, genetic specialists, and gynecologists must be approached before pregnancy planning. In addition, women should be given counseling regarding pregnancy-related issues and AoD. TEE is beneficial in assessing heart valve defects in this stage.
-
During Pregnancy: Evaluation of aortic root diameter and heart function must be done. Although rare, if the aortic root diameter is significantly increased, it threatens both the mother and fetus. In such cases, patients can choose to terminate the pregnancy. TTE for aortic size should be done. Beta-blockers are safe and useful for controlling blood pressure and heart rate. Metoprolol is preferred. Patients on beta-blocker therapy are at an increased risk of gestational diabetes. Hence, doctors should properly manage it. In addition, fetal ultrasound is a must to rule out congenital disabilities and check fetal growth.
-
Delivery: A rule of thumb is to continue with normal delivery if the aortic diameter is less than four cm. An elective cesarean section with epidural anesthesia is recommended if the aortic diameter is 4 to 4.5 cm or more than 4.5 cm. The epidural anesthesia keeps blood pressure under control. A quick diagnosis and management of post-partum bleeding are important.
-
Post-Delivery: Patients are at a higher risk for dissection post-delivery. For high-risk patients, weekly and for low-risk, monthly follow-ups for up to six months are advised. Immediate future pregnancies are not advocated. Beta-blockers should be continued for the lactating phase.
Conclusion
Pregnant women with MFS are at major risk due to the added stress on the heart. Careful planning and consultation with the gynecologist, geneticist, and cardiologist ensure a fruitful and positive outcome. Prior counseling about AoD and cautious surveillance of both mother and fetus is of utmost importance.